Answers are grounded in this paper and cite their sources.
The AMR Diagnostics Use Accelerator Program was established to address antimicrobial resistance. Here, we bring into broad perspective the findings and missed opportunities of the first phase of the program and look toward the second phase.
No takes yet. Share an insight, caveat, or question.
Nkeramahame et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: